{"id":"https://openalex.org/W2944635848","doi":null,"title":"New Drug for Triple-Negative Breast Cancer","display_name":"New Drug for Triple-Negative Breast Cancer","alternate_titles":[],"publication_year":2011,"publication_date":"2011-01-12","ids":{"openalex":"https://openalex.org/W2944635848","mag":"2944635848"},"language":"en","primary_location":{"id":"mag:2944635848","doi":null,"is_oa":false,"landing_page_url":"https://www.cancernetwork.com/news/new-drug-triple-negative-breast-cancer","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"parent_works":[],"lineage":["https://openalex.org/W2944635848"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Rachel Warren","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Rachel Warren","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.9067000150680542,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.9067000150680542,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.07750000059604645,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.0071000000461936,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":0.9079999923706055},{"id":"https://openalex.org/keywords/iniparib","display_name":"iniparib","score":0.9449999928474426},{"id":"https://openalex.org/keywords/metastatic-breast-cancer","display_name":"metastatic breast cancer","score":0.8069999814033508},{"id":"https://openalex.org/keywords/parp-inhibitors","display_name":"PARP inhibitors","score":0.6729999780654907},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.7620000243186951},{"id":"https://openalex.org/keywords/survival","display_name":"survival","score":0.7950000166893005},{"id":"https://openalex.org/keywords/drug-toxicity","display_name":"drug toxicity","score":0.6159999966621399}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7285091876983643},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6912969350814819},{"id":"https://openalex.org/C2780110267","wikidata":"https://www.wikidata.org/wiki/Q7843332","display_name":"Triple-negative breast cancer","level":4,"score":0.6547147035598755},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5742748975753784},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5147219300270081},{"id":"https://openalex.org/C2992734768","wikidata":"https://www.wikidata.org/wiki/Q48964","display_name":"Triple negative","level":4,"score":0.49507132172584534},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.47503238916397095},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.45830726623535156},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4470434784889221},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.12179464101791382}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2944635848","doi":null,"is_oa":false,"landing_page_url":"https://www.cancernetwork.com/news/new-drug-triple-negative-breast-cancer","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2150838352","https://openalex.org/W2111429259","https://openalex.org/W81020555","https://openalex.org/W2589359420","https://openalex.org/W4300986560","https://openalex.org/W2030566540","https://openalex.org/W1905741998","https://openalex.org/W2936174012","https://openalex.org/W2934251480","https://openalex.org/W3110717932"],"abstract_inverted_index":{"Researchers":[0],"at":[1],"Baylor":[2],"and":[3,29],"affiliated":[4],"institutions":[5],"reported":[6],"in":[7],"the":[8,12,19,26],"January":[9],"issue":[10],"of":[11,16,21,31],"New":[13],"England":[14],"Journal":[15],"Medicine":[17],"that":[18],"addition":[20],"iniparib":[22],"to":[23],"chemotherapy":[24],"improves":[25],"clinical":[27],"benefit":[28],"survival":[30],"patients":[32],"with":[33],"metastatic":[34],"triple-negative":[35],"breast":[36],"cancer,":[37],"without":[38],"significantly":[39],"increased":[40],"toxic":[41],"effects.":[42]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2944635848","counts_by_year":[],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2019-05-16T00:00:00"}
